MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/1878-0261.13207

Медицинская библиотека · Molecular oncology · 2022

High CD34 surface expression in BCP-ALL predicts poor induction therapy response and is associated with altered expression of genes related to cell migration and adhesion.

Modvig Signe, Wernersson Rasmus, Øbro Nina Friesgaard, Olsen Lars Rønn, Christensen Claus, Rosthøj Susanne, Degn Matilda, Jürgensen Gitte Wullf, Madsen Hans O, Albertsen Birgitte Klug, Wehner Peder Skov, Rosthøj Steen, Lilljebjörn Henrik, Fioretos Thoas, Schmiegelow Kjeld, Marquart Hanne Vibeke

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Minimal residual disease (MRD) constitutes the most important prognostic factor in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Flow cytometry is widely used in MRD assessment, yet little is known regarding the effect of different immunophenotypic subsets on outcome. In this study of 200 BCP-ALL patients, we found that a CD34-positive, CD38 dim-positive, nTdT dim-positive immunophenotype on the leukemic blasts was associated with poor induction therapy response and predicted an MRD level at the end of induction therapy (EOI) of ≥ 0.001. CD34 expression was strongly and positively associated with EOI MRD, whereas CD34-negative patients had a low relapse risk. Further, CD34 expression increased from diagnosis to relapse. CD34 is a stemness-associated cell-surface molecule, possibly involved in cell adhesion/migration or survival. Accordingly, genes associated with stemness were overrepresented among the most upregulated genes in CD34-positive leukemias, and protein-protein interaction networks showed an overrepresentation of genes associated with cell migration, cell adhesion, and negative regulation of apoptosis. The present work is the first to demonstrate a CD34-negative immunophenotype as a good prognostic factor in ALL, whereas high CD34 expression is associated with poor therapy response and an altered gene expression profile reminiscent of migrating cancer stem-like cells.

Для цитирования: Modvig Signe, Wernersson Rasmus, Øbro Nina Friesgaard, Olsen Lars Rønn, Christensen Claus, Rosthøj Susanne, Degn Matilda, Jürgensen Gitte Wullf, Madsen Hans O, Albertsen Birgitte Klug, Wehner Peder Skov, Rosthøj Steen, Lilljebjörn Henrik, Fioretos Thoas, Schmiegelow Kjeld, Marquart Hanne Vibeke. High CD34 surface expression in BCP-ALL predicts poor induction therapy response and is associated with altered expression of genes related to cell migration and adhesion.. Molecular oncology. 2022. DOI: 10.1002/1878-0261.13207.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.